Clinical Trial Results:
Randomised phase II study of the combination of oral vinorelbine with capecitabine versus a sequential regimen of oral vinorelbine and capecitabine versus the combination of docetaxel and capecitabine in patients with metastatic breast cancer previously treated with anthracyclines.
Summary
|
|
EudraCT number |
2004-005205-30 |
Trial protocol |
BE AT |
Global completion date |
09 Dec 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
13 Feb 2016
|
First version publication date |
13 Feb 2016
|
Other versions |
|
Summary report(s) |
2004-005205-30 - Phase 2 Oral vinorelbine in Breast cancer |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.